146 related articles for article (PubMed ID: 26898347)
41. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Thorsen K; Sørensen KD; Brems-Eskildsen AS; Modin C; Gaustadnes M; Hein AM; Kruhøffer M; Laurberg S; Borre M; Wang K; Brunak S; Krainer AR; Tørring N; Dyrskjøt L; Andersen CL; Orntoft TF
Mol Cell Proteomics; 2008 Jul; 7(7):1214-24. PubMed ID: 18353764
[TBL] [Abstract][Full Text] [Related]
42. An exon-centric perspective.
Blencowe BJ
Biochem Cell Biol; 2012 Oct; 90(5):603-12. PubMed ID: 22779775
[TBL] [Abstract][Full Text] [Related]
43. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
44. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.
Guo J; Jia J; Jia R
Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554
[TBL] [Abstract][Full Text] [Related]
45. EventPointer: an effective identification of alternative splicing events using junction arrays.
Romero JP; Muniategui A; De Miguel FJ; Aramburu A; Montuenga L; Pio R; Rubio A
BMC Genomics; 2016 Jun; 17():467. PubMed ID: 27315794
[TBL] [Abstract][Full Text] [Related]
46. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells.
Yeo GW; Coufal NG; Liang TY; Peng GE; Fu XD; Gage FH
Nat Struct Mol Biol; 2009 Feb; 16(2):130-7. PubMed ID: 19136955
[TBL] [Abstract][Full Text] [Related]
47. Mapping Whole-Transcriptome Splicing in Mouse Hematopoietic Stem Cells.
Goldstein O; Meyer K; Greenshpan Y; Bujanover N; Feigin M; Ner-Gaon H; Shay T; Gazit R
Stem Cell Reports; 2017 Jan; 8(1):163-176. PubMed ID: 28041879
[TBL] [Abstract][Full Text] [Related]
48. Overestimation of alternative splicing caused by variable probe characteristics in exon arrays.
Gaidatzis D; Jacobeit K; Oakeley EJ; Stadler MB
Nucleic Acids Res; 2009 Sep; 37(16):e107. PubMed ID: 19528075
[TBL] [Abstract][Full Text] [Related]
49. Cancer-associated regulation of alternative splicing.
Venables JP; Klinck R; Koh C; Gervais-Bird J; Bramard A; Inkel L; Durand M; Couture S; Froehlich U; Lapointe E; Lucier JF; Thibault P; Rancourt C; Tremblay K; Prinos P; Chabot B; Elela SA
Nat Struct Mol Biol; 2009 Jun; 16(6):670-6. PubMed ID: 19448617
[TBL] [Abstract][Full Text] [Related]
50. Multiple roles of RBM4 in muscle cell differentiation.
Lin JC; Tarn WY
Front Biosci (Schol Ed); 2012 Jan; 4(1):181-9. PubMed ID: 22202052
[TBL] [Abstract][Full Text] [Related]
51. IGF2 mRNA binding protein 3 (IMP3) mediated regulation of transcriptome and translatome in glioma cells.
Bhargava S; Patil V; Shah RA; Somasundaram K
Cancer Biol Ther; 2018 Jan; 19(1):42-52. PubMed ID: 28485999
[TBL] [Abstract][Full Text] [Related]
52. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
Warzecha CC; Shen S; Xing Y; Carstens RP
RNA Biol; 2009; 6(5):546-62. PubMed ID: 19829082
[TBL] [Abstract][Full Text] [Related]
53. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
[TBL] [Abstract][Full Text] [Related]
54. Genomic analysis of RNA alternative splicing in cancers.
Xing Y
Front Biosci; 2007 May; 12():4034-41. PubMed ID: 17485356
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
[TBL] [Abstract][Full Text] [Related]
56. Gene Array Analyzer: alternative usage of gene arrays to study alternative splicing events.
Gellert P; Teranishi M; Jenniches K; De Gaspari P; John D; Kreymborg Kg; Braun T; Uchida S
Nucleic Acids Res; 2012 Mar; 40(6):2414-25. PubMed ID: 22123740
[TBL] [Abstract][Full Text] [Related]
57. Transcriptome instability as a molecular pan-cancer characteristic of carcinomas.
Sveen A; Johannessen B; Teixeira MR; Lothe RA; Skotheim RI
BMC Genomics; 2014 Aug; 15(1):672. PubMed ID: 25109687
[TBL] [Abstract][Full Text] [Related]
58. Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Chen JY; Liu LP; Xu JF
Onco Targets Ther; 2017; 10():339-345. PubMed ID: 28138257
[TBL] [Abstract][Full Text] [Related]
59. RBM4-Nova1-SRSF6 splicing cascade modulates the development of brown adipocytes.
Lin JC; Chi YL; Peng HY; Lu YH
Biochim Biophys Acta; 2016 Nov; 1859(11):1368-1379. PubMed ID: 27535496
[TBL] [Abstract][Full Text] [Related]
60. A random effects model for the identification of differential splicing (REIDS) using exon and HTA arrays.
Van Moerbeke M; Kasim A; Talloen W; Reumers J; Göhlmann HWH; Shkedy Z
BMC Bioinformatics; 2017 May; 18(1):273. PubMed ID: 28545391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
